Contact Us
Veterinary Pharmaceuticals Market Report 2026
Veterinary Pharmaceuticals Market Report Infographic Image
Item added to cart!

Published : January 2026

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Veterinary Pharmaceuticals Market Report 2026

Global Outlook – By Type (Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types), By Type Of Animal (Livestock, Companion Animals), By Type Of Vaccine (Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Type Of Vaccines), By Route Of Administration (Oral, Parenteral, Topical, Other Routes Of Administrations), By End User (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Veterinary Pharmaceuticals Market Overview

• Veterinary Pharmaceuticals market size has reached to $34.92 billion in 2025

• Expected to grow to $46.88 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%

• Growth Driver: Rising Pet Ownership Fuels Demand For Veterinary Pharmaceuticals

• Market Trend: Innovative Veterinary Pharmaceutical Products Meeting Unique Pet Health Needs

North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Pharmaceuticals Market?

Veterinary pharmaceuticals are a class of drugs that are pharmacologically active and used to control, prevent, and treat diseases in animals. They have an effect when administered to animals and are rapidly broken down into active ingredients due to small intestine metabolism.

The main types of veterinary pharmaceuticals include veterinary vaccines, veterinary antibiotics, veterinary parasiticides, and other types. Veterinary vaccines provide protection against one or more diseases, which can lower the severity or prevent certain diseases entirely. The routes of administration include oral and other routes of administration for animal types, including companion animals and livestock animals. The vaccines include inactivated vaccines, attenuated vaccines, recombinant vaccines, and others that are provided by various end-users such as veterinary hospitals, veterinary clinics, pharmacies and drug stores.

Veterinary Pharmaceuticals market report bar graph

What Is The Veterinary Pharmaceuticals Market Size and Share 2026?

The veterinary pharmaceuticals market size has grown strongly in recent years. It will grow from $34.92 billion in 2025 to $37.01 billion in 2026 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to increasing prevalence of animal diseases, rising livestock population, growth in companion animals, government regulations supporting animal health, advancements in veterinary research.

What Is The Veterinary Pharmaceuticals Market Growth Forecast?

The veterinary pharmaceuticals market size is expected to see strong growth in the next few years. It will grow to $46.88 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to emerging biopharmaceutical technologies, increasing r&d in veterinary drugs, adoption of precision medicine for animals, growth in preventive veterinary healthcare, rising investments in companion animal pharmaceuticals. Major trends in the forecast period include development of novel veterinary drugs, growth of companion animal healthcare, rising use of combination therapies, expansion of oral and topical formulations, emphasis on rapid metabolism and bioavailability.

Customer representative image Book your 30 minutes free consultation with our research experts

Global Veterinary Pharmaceuticals Market Segmentation

1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types

2) By Type Of Animal: Livestock, Companion Animals

3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Type Of Vaccines

4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administrations

5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores

Subsegments:

1) By Veterinary Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines

2) By Veterinary Antibiotics: Penicillins, Cephalosporins, Tetracyclines, Fluoroquinolones, Macrolides

3) By Veterinary Parasiticides: Endoparasiticides, Ectoparasiticides, Endectocides, Antiprotozoals

4) By Other Types: Anti-Inflammatory Drugs, Analgesics, Hormonal Medications, Antifungals

What Is The Driver Of The Veterinary Pharmaceuticals Market?

The increasing pet ownership is expected to boost the growth of the veterinary pharmaceuticals market going forward. Pet ownership refers to the legal and ethical responsibility of individuals or households for the care, maintenance, and well-being of domesticated animals, commonly known as pets. The increasing pet ownership is rising due to people seeking companionship and emotional support. Increasing pet ownership drives greater demand for veterinary care, which in turn stimulates the growth of veterinary pharmaceuticals by expanding the market for medications, vaccines, and preventive treatments necessary to maintain the health and well-being of a larger and more diverse population of companion animals. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the increasing pet ownership is driving the growth of the veterinary pharmaceuticals industry.

Key Players In The Global Veterinary Pharmaceuticals Market

Major companies operating in the veterinary pharmaceuticals market are Zoetis Inc, Merck & Co. Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd.

Global Veterinary Pharmaceuticals Market Trends and Insights

Major companies operating in the veterinary pharmaceuticals market are developing new products such as molidustat oral suspensions to meet larger customer bases, more sales, and increase revenue. Molidustat oral suspension refers to a medication used for the control of nonregenerative anemia associated with chronic kidney disease (CKD) in cats. For instance, in September 2023, Elanco Animal Health Incorporated, a US-based pharmaceutical company, launched, Varenzin-CA1 (molidustat oral suspension), the first and only medication to manage non-regenerative anemia in cats with chronic kidney disease (CKD) and received provisional approval from the U.S. Food and Drug Administration (FDA). Varenzin-CA1 has the unique feature of being an innovative needle-free oral suspension solution for cats that can be administered at home without the requirement for in-clinic injections. This is also the first medication for cats to receive expanded conditional approval, a route to the market that promotes the creation of novel therapies and broadens the options for treating animals with unusual conditions, serious or life-threatening illnesses, or illnesses for which there are no effective or available treatments.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Veterinary Pharmaceuticals Market?

In April 2025, Swedencare AB (publ), a Sweden based provider of animal health and wellness products including pharmaceuticals, supplements, and specialty veterinary formulations for companion animals, acquired Summit Veterinary Pharmaceuticals Limited for approximately $38 million (£30 million). With this acquisition, Swedencare sought to strengthen its veterinary pharmaceuticals portfolio and deepen its presence in the UK and Hong Kong markets by integrating Summit’s established specialty pharma business enhancing product offerings for veterinary professionals and expanding its geographic footprint in key growth regions. Summit Veterinary Pharmaceuticals Limited is a UK-based developer, manufacturer, and seller of customized specialty veterinary pharmaceutical products exclusively for veterinary professionals in the UK and Hong Kong.

Regional Outlook

North America was the largest region in the veterinary pharmaceuticals market in 2025. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Pharmaceuticals Market?

The veterinary pharmaceuticals market consists of sales of biological drugs, biosimilars, monoclonal antibodies, sedatives, and antihistaminic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Veterinary Pharmaceuticals Market Report 2026?

The veterinary pharmaceuticals market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary pharmaceuticals industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Veterinary Pharmaceuticals Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $37.01 billion
Revenue Forecast In 2035 $46.88 billion
Growth Rate CAGR of 6.0% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Type Of Animal, Type Of Vaccine, Route Of Administration, End User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Zoetis Inc, Merck & Co. Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Veterinary Pharmaceuticals Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Veterinary Pharmaceuticals Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Veterinary Pharmaceuticals Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Veterinary Pharmaceuticals Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Development Of Novel Veterinary Drugs

4.2.2 Growth Of Companion Animal Healthcare

4.2.3 Rising Use Of Combination Therapies

4.2.4 Expansion Of Oral And Topical Formulations

4.2.5 Emphasis On Rapid Metabolism And Bioavailability

5. Veterinary Pharmaceuticals Market Analysis Of End Use Industries

5.1 Veterinary Hospitals

5.2 Veterinary Clinics

5.3 Pharmacies And Drug Stores

5.4 Animal Health Research Institutes

5.5 Universities & Veterinary Colleges

6. Veterinary Pharmaceuticals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Pharmaceuticals Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Veterinary Pharmaceuticals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Veterinary Pharmaceuticals Market Size, Comparisons And Growth Rate Analysis

7.3. Global Veterinary Pharmaceuticals Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Veterinary Pharmaceuticals Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Veterinary Pharmaceuticals Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Veterinary Pharmaceuticals Market Segmentation

9.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types

9.2. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Livestock, Companion Animals

9.3. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Type Of Vaccines

9.4. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Topical, Other Routes Of Administrations

9.5. Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores

9.6. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines

9.7. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Penicillins, Cephalosporins, Tetracyclines, Fluoroquinolones, Macrolides

9.8. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Parasiticides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Endoparasiticides, Ectoparasiticides, Endectocides, Antiprotozoals

9.9. Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Anti-Inflammatory Drugs, Analgesics, Hormonal Medications, Antifungals

10. Veterinary Pharmaceuticals Market Regional And Country Analysis

10.1. Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Veterinary Pharmaceuticals Market

11.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Veterinary Pharmaceuticals Market

12.1. China Veterinary Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Veterinary Pharmaceuticals Market

13.1. India Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Veterinary Pharmaceuticals Market

14.1. Japan Veterinary Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Veterinary Pharmaceuticals Market

15.1. Australia Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Veterinary Pharmaceuticals Market

16.1. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Veterinary Pharmaceuticals Market

17.1. South Korea Veterinary Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Veterinary Pharmaceuticals Market

18.1. Taiwan Veterinary Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Veterinary Pharmaceuticals Market

19.1. South East Asia Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Veterinary Pharmaceuticals Market

20.1. Western Europe Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Veterinary Pharmaceuticals Market

21.1. UK Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Veterinary Pharmaceuticals Market

22.1. Germany Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Veterinary Pharmaceuticals Market

23.1. France Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Veterinary Pharmaceuticals Market

24.1. Italy Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Veterinary Pharmaceuticals Market

25.1. Spain Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Veterinary Pharmaceuticals Market

26.1. Eastern Europe Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Veterinary Pharmaceuticals Market

27.1. Russia Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Veterinary Pharmaceuticals Market

28.1. North America Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Veterinary Pharmaceuticals Market

29.1. USA Veterinary Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Veterinary Pharmaceuticals Market

30.1. Canada Veterinary Pharmaceuticals Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Veterinary Pharmaceuticals Market

31.1. South America Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Veterinary Pharmaceuticals Market

32.1. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Veterinary Pharmaceuticals Market

33.1. Middle East Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Veterinary Pharmaceuticals Market

34.1. Africa Veterinary Pharmaceuticals Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Veterinary Pharmaceuticals Market, Segmentation By Type, Segmentation By Type Of Animal, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Veterinary Pharmaceuticals Market Regulatory and Investment Landscape

36. Veterinary Pharmaceuticals Market Competitive Landscape And Company Profiles

36.1. Veterinary Pharmaceuticals Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Veterinary Pharmaceuticals Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Veterinary Pharmaceuticals Market Company Profiles

36.3.1. Zoetis Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Boehringer Ingelheim International Gmb Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Ceva Sante Animale Overview, Products and Services, Strategy and Financial Analysis

37. Veterinary Pharmaceuticals Market Other Major And Innovative Companies

Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda

38. Global Veterinary Pharmaceuticals Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

40. Veterinary Pharmaceuticals Market High Potential Countries, Segments and Strategies

40.1 Veterinary Pharmaceuticals Market In 2030 - Countries Offering Most New Opportunities

40.2 Veterinary Pharmaceuticals Market In 2030 - Segments Offering Most New Opportunities

40.3 Veterinary Pharmaceuticals Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Veterinary Pharmaceuticals Market, Overview Of Key Products - Product Examples
  • Table 2: Global Veterinary Pharmaceuticals Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Veterinary Pharmaceuticals Market, Supply Chain Analysis
  • Table 4: Global Veterinary Pharmaceuticals Market, Major Raw Material Providers
  • Table 5: Global Veterinary Pharmaceuticals Market, Major Resource Providers
  • Table 6: Global Veterinary Pharmaceuticals Market, Major Manufacturers (Suppliers)
  • Table 7: Global Veterinary Pharmaceuticals Market, Major Distributors And Channel Partners
  • Table 8: Global Veterinary Pharmaceuticals Market, Key Technologies & Future Trends
  • Table 9: Global Veterinary Pharmaceuticals Market, Major Trends
  • Table 10: Global Veterinary Pharmaceuticals Market, Major End Users
  • Table 11: Global Veterinary Pharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Veterinary Pharmaceuticals Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Veterinary Pharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Veterinary Pharmaceuticals Market - TAM, US$ Billion, 2025
  • Table 15: Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Parasiticides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Global Veterinary Pharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 99: Global Veterinary Pharmaceuticals Market - Company Scoring Matrix
  • Table 100: Zoetis Inc Financial Performance
  • Table 101: Merck & Co. Inc Financial Performance
  • Table 102: Boehringer Ingelheim International Gmb Financial Performance
  • Table 103: Elanco Animal Health Incorporated Financial Performance
  • Table 104: Ceva Sante Animale Financial Performance
  • Table 105: Global Veterinary Pharmaceuticals Market, Competitive Benchmarking (In USD Billions)
  • Table 106: Global Veterinary Pharmaceuticals Market, Competitive Dashboard
  • Table 107: Global Veterinary Pharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 108: Global, Veterinary Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 109: Global, Veterinary Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Type Of Animal, 2025 – 2030
  • Table 110: Global, Veterinary Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Type Of Vaccine, 2025 – 2030

List Of Figures

    Figure 1: Global Veterinary Pharmaceuticals Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Veterinary Pharmaceuticals Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Veterinary Pharmaceuticals Market, Supply Chain Analysis
  • Figure 4: Global Veterinary Pharmaceuticals Market, Major Raw Material Providers
  • Figure 5: Global Veterinary Pharmaceuticals Market, Major Resource Providers
  • Figure 6: Global Veterinary Pharmaceuticals Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Veterinary Pharmaceuticals Market, Major Distributors And Channel Partners
  • Figure 8: Global Veterinary Pharmaceuticals Market, Key Technologies & Future Trends
  • Figure 9: Global Veterinary Pharmaceuticals Market, Major Trends
  • Figure 10: Global Veterinary Pharmaceuticals Market, Major End Users
  • Figure 11: Global Veterinary Pharmaceuticals Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Veterinary Pharmaceuticals Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Veterinary Pharmaceuticals Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Veterinary Pharmaceuticals Market - TAM, US$ Billion, 2025
  • Figure 15: Global Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Veterinary Pharmaceuticals Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Vaccines, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Antibiotics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Veterinary Parasiticides, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Veterinary Pharmaceuticals Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Veterinary Pharmaceuticals Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Veterinary Pharmaceuticals Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Veterinary Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Veterinary Pharmaceuticals Market, Segmentation By Type Of Animal, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Veterinary Pharmaceuticals Market, Segmentation By Type Of Vaccine, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Global Veterinary Pharmaceuticals Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 99: Global Veterinary Pharmaceuticals Market - Company Scoring Matrix
  • Figure 100: Zoetis Inc Financial Performance
  • Figure 101: Merck & Co. Inc Financial Performance
  • Figure 102: Boehringer Ingelheim International Gmb Financial Performance
  • Figure 103: Elanco Animal Health Incorporated Financial Performance
  • Figure 104: Ceva Sante Animale Financial Performance
  • Figure 105: Global Veterinary Pharmaceuticals Market, Competitive Benchmarking (In USD Billions)
  • Figure 106: Global Veterinary Pharmaceuticals Market, Competitive Dashboard
  • Figure 107: Global Veterinary Pharmaceuticals Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 108: Global, Veterinary Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 109: Global, Veterinary Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Type Of Animal, 2025 – 2030
  • Figure 110: Global, Veterinary Pharmaceuticals Market Size Gain ($ Billion), Segmentation By Type Of Vaccine, 2025 – 2030

Frequently Asked Questions

The Veterinary Pharmaceuticals market was valued at $34.92 billion in 2025, increased to $34.92 billion in 2026, and is projected to reach $46.88 billion by 2030. request a sample here

The expected CAGR for the Veterinary Pharmaceuticals market during the forecast period 2025–2030 is 6.1%. request a sample here

Major growth driver of the market includes: The increasing pet ownership is expected to boost the growth of the veterinary pharmaceuticals market going forward. Pet ownership refers to the legal and ethical responsibility of individuals or households for the care, maintenance, and well-being of domesticated animals, commonly known as pets. The increasing pet ownership is rising due to people seeking companionship and emotional support. Increasing pet ownership drives greater demand for veterinary care, which in turn stimulates the growth of veterinary pharmaceuticals by expanding the market for medications, vaccines, and preventive treatments necessary to maintain the health and well-being of a larger and more diverse population of companion animals. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, the increasing pet ownership is driving the growth of the veterinary pharmaceuticals market. in the Veterinary Pharmaceuticals market. For further insights on this market, request a sample here

The veterinary pharmaceuticals market covered in this report is segmented –
1) By Type: Veterinary Vaccines, Veterinary Antibiotics, Veterinary Parasiticides, Other Types
2) By Type Of Animal: Livestock, Companion Animals
3) By Type Of Vaccine: Inactivated Vaccines, Attenuated Vaccines, Recombinant Vaccines, Other Type Of Vaccines
4) By Route Of Administration: Oral, Parenteral, Topical, Other Routes Of Administrations
5) By End User: Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores Subsegments:
1) By Veterinary Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, DNA Vaccines, Subunit Vaccines
2) By Veterinary Antibiotics: Penicillins, Cephalosporins, Tetracyclines, Fluoroquinolones, Macrolides
3) By Veterinary Parasiticides: Endoparasiticides, Ectoparasiticides, Endectocides, Antiprotozoals
4) By Other Types: Anti-Inflammatory Drugs, Analgesics, Hormonal Medications, Antifungals
request a sample here

Major trend in this market includes: Innovative Veterinary Pharmaceutical Products Meeting Unique Pet Health Needs For further insights on this market, request a sample here.

Major companies operating in the Veterinary Pharmaceuticals market are Major companies operating in the veterinary pharmaceuticals market are Zoetis Inc, Merck & Co. Inc, Boehringer Ingelheim International Gmb, Elanco Animal Health Incorporated, Ceva Sante Animale, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol S.A., Phibro Animal Health Corporation, Kyoritsu Seiyaku Corporation, Hebei Chengshengtang Animal Pharmaceutical, Shijiazhuang Fengqiang Animal Pharmaceutical Co .Ltd, Vvaan Lifesciences Private Limited, Century Pharmaceuticals Limited, Cargill India Pvt. Ltd., Jurox Pty Ltd, Bayer, Veteq, Nimrod Veterinary Products Ltd., Bimeda, Orion Animal Health, Petmedix, Eco Animal Health, Teknofarma, Farmavet, Candioli Pharma, Suanfarma, Marino Ibericamed, MPA veterinary, Swetrade Pharmaceuticals AB, Animalcare, VET-AGRO Sp. z o. o, CANPOLAND SA, Cymedica, VIC Group, NITA-FARM, Apicenna LLC, Delos Medica, Provet Group, Bioveta AS, Veterinarski Zavod Subotica, PharmaGal s.r.o., Trifecta Pharmaceuticals USA LLC., Alberta Veterinary Laboratories Ltd., Veterinary Purchasing Co. Ltd, UCBVET, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, Lemavet, Primo Veterinary Medicines Trading LLC., AL Kubara Veterinary Medicines Trading LLC., Eurovets Veterinary Suppliers, Saudi Pharmaceutical Industries, DBK Pharma S.A.E., Dawa Limited, Neimeth International Pharmaceuticals, Osy-Adamu Pharmaceutical Co., Global Vet (U) Ltd. request a sample here.

North America was the largest region in the veterinary pharmaceuticals market in 2025. Asia-Pacific was the second-largest region in the global veterinary pharmaceuticals market report. The regions covered in the veterinary pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon